Bausch Health
BHC
#4764
Rank
C$2.81 B
Marketcap
C$7.53
Share price
-2.12%
Change (1 day)
10.53%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): C$0.57

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C$0.57. an increase over its 2024 EPS that were of C-$0.16.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025C$0.57-450%
2024C-$0.16-92.59%
2023C-$2.21160.89%
2022C-$0.85-76.64%
2021C-$3.6268.45%
2020C-$2.15-68.91%
2019C-$6.91-57.11%
2018C-$16.12-272.22%
2017C$9.36-199.29%
2016C-$9.43798.7%
2015C-$1.05-128.31%
2014C$3.70-204.62%
2013C-$3.54602.7%
2012C-$0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.33-157.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.29-326.19%๐Ÿ‡บ๐Ÿ‡ธ USA